10YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| NT157 | NT-157 | 1384426-12-3 |
| AZD8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
| H 89 2HCl | H-89二盐酸盐 | 130964-39-5 |
| BAY87-2243 | BAY87-2243 | 1227158-85-1 |
| ML264 | (2E)-3-(3-氯苯基)-N-[2-[甲基(四氢-1,1-二氧代-2H-噻喃-4-基)氨基]-2-氧代乙基]-2-丙烯酰胺 | 1550008-55-3 |
| LY2090314 | LY 2090314 | 603288-22-8 |
| ARM-390 HCl | ARM-390HCL | 209808-47-9 |
| pardoprunox.HCl | 盐酸帕多芦诺 | 269718-83-4 |
| LSN3154567 (Nampt-IN-1) | 2-羟基-2-甲基-N-[1,2,3,4-四氢-2-[2-(3-吡啶基氧基)乙酰基]-6-异喹啉基]-1-丙烷磺酰胺 | 1698878-14-6 |
| APR-246 | APR-246 | 5291-32-7 |
| Epoxomicin | 艾泼米辛 | 134381-21-8 |
| TAPI-2 | CS-2628 | 187034-31-7 |
| LAQ824 (Dacinostat) | 达诺司他 | 404951-53-7 |
| BIX 02188 | 3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-2-氧代-1H-吲哚-6-甲酰胺 | 1094614-84-2 |
| AT7519 Hydrochloride | N-(4-哌啶基)-4-(2,6-二氯苄氨基)-1H-吡唑-3-羧胺盐酸盐 | 902135-91-5 |
| RGFP 966 | RGFP966 | 1357389-11-7 |
| Erastin | ERASTIN | 571203-78-6 |
| Ro31-8220MsOH | RO-31-8220 | 138489-18-6 |
| BIBS39 | BIBS39 | 133085-33-3 |
| TP-3654 | TP3654 | 1361951-15-6 |
| JNJ-42041935 | JNJ 42041935 | 1193383-09-3 |
| AZ-33 | AZ-33 | 1370290-34-8 |
| TUG 891 | TUG 891 | 1374516-07-0 |
| TM 5275 sodium salt | CS-2524 | 1103926-82-4 |
| KML-29 | KML-29 | 1380424-42-9 |
| Salermide | CS-2458 | 1105698-15-4 |
| JZL184 | JZL-184 | 1101854-58-3 |
| MK8931 | MK8931 | 1613380-81-6 |
| Pimodivir (VX-787) | VX-787 | 1629869-44-8 |
| CPI-169 | 化合物CPI169 | 1450655-76-1 |
| NSC12 | CS-2161 | 102586-30-1 |
| BGB-283(GDC-0810) | BGB-TG-P1 | 1446090-77-2 |
| SCH 23390(HCI) | 125941-87-9 | 125941-87-9 |
| (Nidufexor)EOS-61760 | NIDUFEXOR | 1773489-72-7 |
| RAF709 | 化合物RAF709 | 1628838-42-5 |
| 瑞加德松 | 313348-27-5 | |
| Napabucasin (BBI608) | 2-乙酰基呋喃并-1,4-萘醌 | 83280-65-3 |
| SLV319 | 362519-49-1 | 362519-49-1 |
| BIX01294 | BIX 01294三盐酸盐水合物 | 1392399-03-9 |
| Lomitapide Mesylate | 甲磺酸洛美他派 | 202914-84-9 |
| nicainoprol | 尼卡普醇 | 76252-06-7 |
| HA-15 | HA-15 | 1609402-14-3 |
| TBPB | 5MG | 634616-95-8 |
| PRIMA-1 | 2,2-双(羟甲基)奎宁环-3-酮 | 5608-24-2 |
| PTC-028 | CS-1497 | 1782970-28-8 |
| MELK-T1(JNJ-47117096) | 1610586-62-3 | |
| TAPI-1 | TAPI-1 | 171235-71-5 |
| RO462005 | RO462005 | 150725-87-4 |
| D-64131 | D-64131 | 74588-78-6 |
| GO6983 | 3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮 | 133053-19-7 |
| VU 0364770 | VU 0364770 | 61350-00-3 |
| RQ 00203078 | 4-(N-(3-氯-5-(三氟甲基)吡啶-2-基)-N-(4-(三氟甲氧基)苄基)氨基磺酰基)苯甲酸 | 1254205-52-1 |
| CP544326 | TAPRENEPAG | 752187-80-7 |
| GSK137647A | 4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺 | 349085-82-1 |
| fluoroclebopride | 4-氨基-5-氯-N-[1-[(4-氟苯基)甲基]-4-哌啶基]-2-甲氧基苯甲酰胺 | 154540-49-5 |
| APD597 | APD597 | 897732-93-3 |
| R-112 | R112 | 575474-82-7 |
| BMS-935177 | 1231889-53-4 | 1231889-53-4 |
| SC79 | 2-氨基-6-氯-ALPHA-氰基-3-(乙氧羰基)-4H-1-苯并吡喃-4-乙酸乙酯 | 305834-79-1 |
| C646 | C646 | 328968-36-1 |
| Scriptaid (GCK1026) | SCRIPTAID | 287383-59-9 |
| ACSS2 inhibitor | 1-(2,3-二(噻吩-2-基)喹啉-6-基)-3-(2-甲氧基乙基)脲 | 5081186-14-9 |
| MS049 | 1502816-23-0 | 1502816-23-0 |
| U73122 | 1-[6-[((17Β)-3-雌酮-1,3,5[10]-三烯-17-基)氨基]乙基]-1H-吡咯-2,5-二酮 | 112648-68-7 |
| CPI-360 | EZH2抑制剂(CPI-360) | 1802175-06-9 |
| calpeptin | CALPEPTIN | 117591-20-5 |
| GSK2292767 | GSK2292767 | 1254036-66-2 |
| Exatecan mesilate | 甲磺酸伊喜替康 | 169869-90-3 |
| Treprostinil | 曲前列尼尔 | 81846-19-7 |
| Olopatadine Hydrochloride | 盐酸奥洛他定 | 140462-76-6 |
| UM-164 | UM-164 | 903564-48-7 |
| SCH23390 | CS-2692 | 87134-87-0 |
| CEP-40783 | CEP-40783 | 1437321-24-8 |
| A-196 | 1982372-88-2 | 1982372-88-2 |
| LevoMilnacipran hydrochloride | 左旋米那普仑盐酸盐 | 175131-60-9 |
| LLY-283 | 化合物 T15767 | 2040291-27-6 |
| Treprostinil diethanolamine | 曲前列尼尔二乙醇胺盐 | 830354-48-8 |
| treprostinil sodium | 曲前列尼尔钠 | 289480-64-4 |
| 15(S)-15-Methyl prostaglandin | 15(S)-15-甲基前列腺素 | 35700-21-1 |
| Eldecalcitol | 艾地骨化醇 | 104121-92-8 |
| MI-503 | MI-503 | 1857417-13-0 |
| ODM203 | ODM203 | 1430723-35-5 |
| blu667 | BLU-667（拉西替尼） | 2097132-94-8 |
| TAS-120 | FGFR抑制剂(FGFR-IN-1) | 1448169-71-8 |
| UNC0379 | UNC0379 | 1620401-82-2 |
| 3-Cyano-7-ethoxycoumarin | 3-氰基-7-乙氧基香豆素 | 117620-77-6 |
| ML204 | 4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE | 5465-86-1 |
| I-BET151(GSK1210151A) | 7-(3,5-二甲基异噁唑-4-基)-8-甲氧基-1-((R)-1-(吡啶-2-基)乙基)-1H-咪唑并[4,5-C]喹啉-2(3H)-酮 | 1300031-49-5 |
| ARV-825 | CS-2252 | 1818885-28-7 |
| dBET6 | 1950634-92-0 | 1950634-92-0 |
| SB225002 | SB225002 | 182498-32-4 |
| LOXO-195 | LOXO-195 | 2097002-61-2 |
| N6-cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-9H-purine-2,6-diamine | N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 | 1246529-32-7 |
| U-104 | U-104 | 178606-66-1 |
| JH-II-127 | JH-II-127 | 1700693-08-8 |
| Isoxazole 9 (ISX-9) | ISX 9 | 832115-62-5 |
| MSX-122 | MSX 122 | 897657-95-3 |
| NIBR189 | NIBR189 | 1599432-08-2 |
| SGC707 | N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1687736-54-4 |
| XY1 | N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1624117-53-8 |
联系方式
